CTAS vs EMR · P/E 51, rev $11.26B vs P/E 34, rev $4.86B
Cintas Corporation (CTAS) versus Emerson Electric Company (EMR) — a side-by-side from cached financials, not a winner call.
Cintas Corporation (CTAS) is a specialty business services company listed on US.
Emerson Electric Company (EMR) is a specialty industrial machinery company listed on NYSE.
Latest reported CTAS revenue for 2026-05-31 was $11.26B. Net income was $2.00B. Revenue was up 8.9% from 2025-05-31 to 2026-05-31. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
Latest reported EMR revenue for 2025-09-30 was $4.86B. Net income was $2.25B. Revenue was up 6.6% from 2025-06-30 to 2025-09-30. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
CTAS currently screens at market cap $89.01B and trailing P/E 51.3. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
Not investment advice. Open the CTAS and EMR stock pages for the full models.
Not investment advice.